Kiora PharmaceuticalsKPRX
13F holders, Q4 2024 (December 31)16holders −2
1new positions
4sold out
$3.31avg. 13F price*
At the end of Q4 2024, 16 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, down 2 from Q3 2024. 1 opened new positions and 4 sold out. The largest holders were AIGH Capital Management LLC ($850K), Rosalind Advisors, Inc. ($827K) and Nantahala Capital Management, LLC ($697K).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $827K |
| Exits | 4 | $759K |
All 13F filers, Q3 2024 → Q4 2024: 255,699 shares bought and 209,810 shares sold, net +45,889 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| AIGH Capital Management LLC | 0.32% | No change | 255,555 | $850K |
| Rosalind Advisors, Inc. | 0.45% | New | 250,555 | $827K |
| Nantahala Capital Management, LLC | 0.05% | No change | 211,110 | $697K |
| Stonepine Capital Management, LLC | 0.54% | Reduce -0.7% | 200,970 | $663K |
| ADAR1 Capital Management, LLC | 0.14% | Add +1.9% | 200,221 | $661K |
| Velan Capital Investment Management LP | 0.35% | No change | 122,223 | $403K |
| Geode Capital Management, LLC | 0.00% | Add +10.2% | 15,957 | $54K |
| BlackRock, Inc. | 0.00% | No change | 1,606 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -38.3% | 1,205 | $4K |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $73 |
| Bank of America Corp. | 0.00% | Reduce -9.1% | 20 | $66 |
| US Bancorp \de | 0.00% | No change | 8 | $26 |
| UBS Group AG | 0.00% | Reduce -99.4% | 2 | $7 |
| Activest Wealth Management | 0.00% | No change | 2 | $7 |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.3% | 2 | $6 |
| SBI Securities Co., Ltd. | 0.00% | — | 1 | $3 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.